Navigation Links
Clarus Ventures Closes $660 Million Fund
Date:2/25/2008

Brings assets under management to $1.2 billion

CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif., Feb. 25 /PRNewswire/ -- Clarus Ventures, LLC ("Clarus Ventures"), a leading life sciences venture capital firm, announced today the single close of Clarus Lifesciences II, L.P. ("Clarus II"), a $660 million fund in Limited Partner commitments. This is the second investment fund formed and managed by Clarus Ventures, since the firm was established in 2005.

Clarus II will invest $20-60 million in biotechnology, specialty pharmaceutical and medical technology companies that are developing innovative products for the treatment of human diseases. The firm's first fund has committed 90 percent of its proceeds to date.

"We have effectively completed the deployment of our first fund and built a diversified portfolio of exciting companies," said Robert Liptak, a Clarus Ventures Managing Director. "These include companies with strong growth in revenue and profitability such as Globus Medical; products near commercialization such as Sientra, Pelikan, Oxford and Zogenix; and those with breakthrough products and technologies such as Aerovance, Centaurus, CoMentis, ESBATech, Pearl, ProActa, SarCode, Taligen, and Variation. We plan to follow a similar investment strategy for Clarus II. With the diversity and depth of our team we believe we can leverage our experience to identify and help grow leading companies in the life sciences field."

The Limited Partner base for Clarus II was effectively the same as in Clarus I. A small, select group of new high-quality investors who knew the firm well also participated.

The Clarus Ventures team is led by Nicholas Galakatos, Dennis Henner, Jeffrey Leiden, Robert Liptak, Nicholas Simon, Michael Steinmetz and Kurt Wheeler, an established group of investment professionals with deep and complementary backgrounds within the life sciences industry. The team uniquely balances broad investing expertise wi
'/>"/>

SOURCE Clarus Ventures, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
2. Jerusalem Global Ventures Announces $200 Million Growth Equity Fund
3. Khosla Ventures and BIOeCON Form KiOR Inc.
4. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
5. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
6. Dan Broderick Joins Prolog Ventures as Partner
7. Hank Plain Joins Morgenthaler Ventures as Partner
8. Ocera Therapeutics Closes $35.5 Million Series C Financing
9. Sinovac Closes $9.75 Million Private Placement
10. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
11. Progentix Orthobiology B.V. Closes Series A Financing Round

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., , PHILADELPHIA, Dec. 3 /PRNewswire-Fir...the global specialty biopharmaceutical company, to...voluntary market withdrawal of one lot of the Atte...Daytrana ® . Shire is taking this action beca...ture may not meet their release liner removal spec...
(Date:12/3/2009)..., , NEW DELHI, India, Dec. 3 ...,Chief Science Officer at Shenzhen Beike Biotechno...oke at a conference on High-Risk Diabetic,Foot Car... China,s leading,stem cell research and regenerati...ganized by the Indian Podiatry Association (IPA), ...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ ...search report is available in its catalogue: ,,...ective ,, http://www.reportlinker.com/p016436...ective.html ,, Incubators are the most critic...r, research, and other applications for providing ...
(Date:12/2/2009)..., , TUSTIN, Calif., Dec. 2 /PRNewswire...sdaq: PPHM ) today reported completion of patient...rial of Cotara® in patients with relapsed gli...brain cancer. Cotara is a targeted monoclonal ant...a potential new treatment for GBM. Cotara specifi...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... The National Academy of,Sciences (NAS) Council a...ief technology officer and executive vice presiden... the Industrial Application of Science. This,prize... intrinsic,scientific importance and with signific...s case, the improvement of crops through biotechno...
...s are attractive candidates for use as the active ...ces. However, it has proven incredibly difficult t...t of the approaches for lining up carbon nanotubes...e devices and are not readily scalable to the leve...sed chips. Now, this seemingly intractable problem...
... 23 Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH)...,today it will be participating in the Wachovia Se...anuary 30, 2008, at 10:15 a.m. Eastern Time., A l...a Zimmer,s,Investor Relations website at http://i...for replay following the conference., About the C...
Other Biology Technology:National Academy of Sciences Recognizes Monsanto's Chief Technology Officer for Development of Agricultural Biotechnology 2Nanotubes go with the flow 2
(Date:12/3/2009)..., The 30-year record low in Antarctic snowmelt th...likely due to concurrent strong positive phases fo...n Oscillation) and SAM (Southern Hemisphere Annula... Professor of Earth & Atmospheric Sciences at The ... who is also on the doctoral faculty at the CUNY G...
(Date:12/2/2009)..., , PHILADELPHIA New study results strengthen th... long period of time have an increased risk for de...or other risk factors. , "This provides one mor...ble," said senior author Michael J. Thun, M.D., M....eillance research at the American Cancer Society. ...
(Date:12/2/2009)..., , PHILADELPHIA Mexican-American adolescents ex...re likely to pick up the habit themselves, and thi...ted with smoking initiation, according to new stud...r smoking in the United States and highlights the ...tion Framework Convention on Tobacco Control, whic...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Breast Cancer Art Shares Journeys of Hope Reconstruction 60018 1Breast Cancer Art Shares Journeys of Hope Reconstruction 60018 2New Hospitals Therapeutic Design Supports Healing Green Practices 60015 1New Hospitals Therapeutic Design Supports Healing Green Practices 60015 2New Hospitals Therapeutic Design Supports Healing Green Practices 60015 3New Hospitals Therapeutic Design Supports Healing Green Practices 60015 4SRI International Researcher Receives International Speech Communication Association 28ISCA 29 Fellow Award 60012 1SRI International Researcher Receives International Speech Communication Association 28ISCA 29 Fellow Award 60012 2SRI International Researcher Receives International Speech Communication Association 28ISCA 29 Fellow Award 60012 3
... Malaria and dengue fever will be the early targe...barcodes" to detect disease. , The University of...(UW) are poised to launch the research after Queen...he National and International Research Alliances P... of two debilitating mosquito-borne diseases, mala...
... Even if you eat right and exercise regularly, ch...tack or stroke. But thanks to new findings by rese...lly shift in your favor. Two unrelated studies rec...http://www.fasebj.org ) describe findings on ather...s of lives. , Both studies involved experiments i...
... , SANTA CRUZ, CA--Huge numbers of fish, seabirds...d discarded after being inadvertently caught durin...s problem is an ongoing challenge to the fishing i.... One recent proposal would compensate for bycatch...t a new analysis suggests that this strategy could...
Other Biology News:New discoveries from Harvard and Baylor get to the heart of cardiovascular disease 2New discoveries from Harvard and Baylor get to the heart of cardiovascular disease 3New study raises concerns about proposed mitigation strategy for marine bycatch 2
...98C679.2.1] to Presenilin 2 Alzheimer's disease (... carry mutations in the presenilin proteins (PSEN1...hese disease-linked mutations result in increased ...n component of amyloid deposits found in AD brains...
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Goat Anti-Human Glypican 2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Beta 2-Microglobulin ELISA Kit from Biomeda Corporation
Biology Products: